Dr Cynthia Coleman and Prof Timothy O’Brien discuss their research on identifying the aetiology of diabetic progenitor cell dysfunction in osteoporosis
A validated method to identify those at most risk from prostate cancer can prevent unnecessary biopsies and reduce pressure on the healthcare sector
In people aged 75 or over, long-term daily aspirin use is linked to a higher than expected risk of disabling or fatal bleeding, according to a new study in The Lancet. While short-term aspirin use after a stroke or heart attack has clear benefits, the authors say that patients over 75 who take aspirin on a daily basis should be prescribed a proton-pump inhibitor (PPI) to reduce the risk of bleeding.
The identification of a molecule called Gremlin 1 in people with rare, aggressive forms of pulmonary hypertension has the potential to lead to new treatments for all types of the disease, Prof Paul McLoughlin told Seán Duke
The HSE has published new research that reveals a significant increase — from 3.5 per cent in 2003 to 24.6 per cent in 2014 — in the number of people smoking ‘roll-your-own’ (RYO) tobacco in Ireland. The findings were released in tandem with World Health Organisation (WHO) World No Tobacco Day on 31 May.
The options for diagnosing and treating depressive disorder are improving and increasing, but the precise causes of depression are still under scientific investigation globally
The benefits of folic acid supplementation in pregnancy up to the first trimester are well proven, but beyond that, the benefits are the subject of continued study
The epidemiological evidence that exercise benefits prostate cancer patients — even those with advanced metastatic forms — is strong. Dr Stephen Finn, an award-winning researcher, is investigating the biological basis for why exercise works. Seán Duke reports
Diabetes Ireland has collaborated with Trinity College, Dublin to develop Diabetes Smart, a 55-minute online series of videos, quizzes and visual tools that people can watch in their own homes.
When people are infected by a virus they release proteins called interferons that interfere with viral replication and strengthen the body’s defences. Dr Nigel Stevenson, Assistant Professor of Intracellular Immunology at Trinity College, Dublin, has spent 10 years developing antiviral drugs to boost this response. He spoke to Seán Duke
The adaptive immune response to viral infection helps protect against new viruses that appear all the time, but there is evidence that the innate immune response can clear out dangerous viruses even faster. Seán Duke spoke to Prof Cliona O’Farrelly, Professor of Comparative Immunology at Trinity College, Dublin
A film has been produced with the support of the Huston School of Film and Digital Media at NUI Galway, on the pivotal work of the Blood Cancer Network Ireland (BCNI). Clinical Trials – A Patient’s Perspective gives viewers a deeper insight into the work carried out by the BCNI, from the perspective of current patient Mr Christopher McEvilly from Oughterard, Co Galway.